Cancer Genetics Inc (NASDAQ:CGIX)

8.76
Delayed Data
As of Mar 02
 0.00 / 0.00%
Today’s Change
4.83
Today|||52-Week Range
19.99
+31.14%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues2.5M3.0M4.3M6.6M
 
 
 
 
 
Cost of Goods Sold3.2M2.7M3.6M4.6M
 
 
 
 
 
Depreciation And Amortization326.8K369.7K353.4K326.5K
 
 
 
 
 
 
Operating ExpensesGross Income-994.6K-98.0K372.6K1.7M
 
 
 
 
 
General Expenses5.3M8.1M8.0M9.5M
 
 
 
 
 
Research And Development1.2M2.1M2.1M2.2M
 
 
 
 
 
Total Operating Expenses8.8M11.2M11.9M14.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-6.3M-8.2M-7.6M-7.8M
 
 
 
 
 
Extraordinary Credit733.4K0.007.5M4.6M
 
 
 
 
Extraordinary Charge-2.0M-10.4M-1.9M-7.5M
 
 
 
 
 
Interest Expense On Debt792.4K1.3M4.7M2.4M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-8.4M-19.9M-6.7M-13.0M
 
 
 
 
 
Income Taxes0.000.000.00-663.9K
 
 
Net Income-8.4M-19.9M-6.7M-12.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS4.0M4.0M4.0M4.7M
 
 
 
 
 
Shares To Calculate EPS Diluted4.0M4.0M4.0M4.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$6.71-$15.61-$10.55-$3.64
 
 
 
 
 
EPS Diluted-$2.09-$4.95-$3.54-$3.64
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account